Search Results 31-40 of 61 for Oral

  1. Variation in postoperative opioid prescribing provides motivation for a more standardized approach - Mayo Clinic

    Eighty percent of patients were prescribed an opioid medication postoperatively, with a median quantity prescribed of 150 oral morphine equivalents (equal to approximately 18 5-mg oxycodone tablets).

  2. Pediatric cardiogenic shock: What is the role of medical and mechanical circulatory support? - Mayo Clinic

    However, depending on disease progression and response to therapy, certain patients may ultimately tolerate transition to an oral heart failure regimen including angiotensin-converting enzyme inhibitors and beta blockers, as well as ...

  3. Cone-beam CT for enhanced bronchoscopic access to pulmonary nodules - Mayo Clinic

    It has been available for over 20 years and has been used by oral surgeons, orthopedic surgeons, vascular surgeons and interventional radiologists, among others.

  4. Culture-expanded, adipose-derived mesenchymal stem cells tested as treatment for knee osteoarthritis - Mayo Clinic

    These treatments include oral nonsteroidal anti-inflammatory medications, viscosupplementation and intra-articular corticosteroid therapies.

  5. PEDIG translates research to evidence-based care for patients at Mayo Clinic - Mayo Clinic

    We continue to investigate alternative approaches, such as oral levodopa as an adjunct to patching.

  6. Endocrinologist-directed multidisciplinary hospital nutrition support service - Mayo Clinic

    Dietitians provide expertise in specialized oral diets and tube feeding formulas.

  7. Autoimmune GI dysmotility: A new direction - Mayo Clinic

    If symptoms and objective testing show improvement, the next step is to maintain that level of reversibility with the minimum effective dosage of maintenance oral immunosuppressants.

  8. The Heart Brain Clinic: Optimal team-based coordinated care - Mayo Clinic

    The effectiveness of the new oral anticoagulants in preventing stroke in patients with PFO has not been evaluated.

  9. Digestive Diseases News - Medical Professionals - Mayo Clinic

    Oral tofacitinib may be approved for ulcerative colitis by the end of 2017.

  10. FMT demonstrates consistently high success rates for recurrent CDI - Mayo Clinic

    Traditional therapy for relapsing CDI — usually oral metronidazole and vancomycin — has limited success because it fails to correct a disordered microbiome and may contribute to further dysbiosis.